Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
    • Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
      • 1-Minute Consult
      • Commentary
      • Current Drug Therapy
      • Editorial
      • Guidelines to Practice
      • Interpreting Key Trials
      • Letter to the Editor
      • Review
      • Smart Testing
      • Symptoms to Diagnosis
      • The Clinical Picture
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
  • COVID-19
    • Curbside Consults Overview
    • Pulmonary/ICU
    • Patient Subsets & Specific Organ Involvement
    • Therapies
    • Imaging & Procedures
    • Patients with Underlying Disease
    • Virus Background & Testing
    • Healthcare System Practice
  • Conference Coverage
    • ASH Annual Meeting
    • AHA Sessions 2020
    • IDWeek 2020
    • CHEST 2020
    • ADA 2020
    • ACC 2020
  • Advertise
    • Media Kit
    • Contact
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
    • Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
  • COVID-19
    • Curbside Consults Overview
    • Pulmonary/ICU
    • Patient Subsets & Specific Organ Involvement
    • Therapies
    • Imaging & Procedures
    • Patients with Underlying Disease
    • Virus Background & Testing
    • Healthcare System Practice
  • Conference Coverage
    • ASH Annual Meeting
    • AHA Sessions 2020
    • IDWeek 2020
    • CHEST 2020
    • ADA 2020
    • ACC 2020
  • Advertise
    • Media Kit
    • Contact
1-Minute Consult

Should we give triple therapy to patients with atrial fibrillation after percutaneous intervention?

Asim Kichloo, MD, Michael M. Aljadah, MD, Farah Wani, MD and Sindhura Ananthaneni, MD
Cleveland Clinic Journal of Medicine October 2020, 87 (10) 599-601; DOI: https://doi.org/10.3949/ccjm.87a.19115
Asim Kichloo
Department of Internal Medicine, St. Mary’s of Michigan, Saginaw, MI; Associate Professor of Internal Medicine, Central Michigan University College of Medicine, Saginaw, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kichlooasim@gmail.com
Michael M. Aljadah
Department of Internal Medicine, Medical College of Wisconsin Affiliated Hospitals, Milwaukee, WI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Farah Wani
Department of Family Medicine, Samaritan Medical Center, Watertown, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sindhura Ananthaneni
Department of Internal Medicine, St. Mary’s of Michigan, Saginaw, MI; Central Michigan University College of Medicine, Saginaw, MI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading
PDF extract preview

You do not have access to the full text of this article, the first page of the PDF of this article appears above.

REFERENCES

  1. ↵
    1. Angiolillo DJ,
    2. Goodman SG,
    3. Bhatt DL, et al
    . Antithrombotic therapy in patients with atrial fibrillation treated with oral anticoagulation undergoing percutaneous coronary intervention: a North American perspective–2018 update. Circulation 2018; 138(5):527–536. doi:10.1161/CIRCULATIONAHA.118.034722
    OpenUrlCrossRef
  2. ↵
    1. Dewilde WJ,
    2. Oirbans T,
    3. Verheugt FW, et al
    . Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet 2013; 381(9872):1107–1115. doi:10.1016/S0140-6736(12)62177-1
    OpenUrlCrossRefPubMed
  3. ↵
    1. Gibson CM,
    2. Mehran R,
    3. Bode C, et al
    . Prevention of bleeding in patients with atrial fibrillation undergoing PCI. N Engl J Med 2016; 375(25):2423–2434. doi:10.1056/NEJMoa1611594
    OpenUrlCrossRefPubMed
  4. ↵
    1. Cannon CP,
    2. Bhatt DL,
    3. Oldgren J, et al
    . Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. N Engl J Med 2017; 377(16):1513–1524. doi:10.1056/NEJMoa1708454
    OpenUrlCrossRefPubMed
  5. ↵
    1. Bainey KR,
    2. Morais J,
    3. Zeymer U,
    4. Welsh RC
    . Atrial fibrillation with percutaneous coronary intervention: navigating the minefield of antithrombotic therapies. Atherosclerosis 2019; 289:118–125. doi:10.1016/j.atherosclerosis.2019.08.021
    OpenUrlCrossRef
  6. ↵
    1. Chang TY,
    2. Lip GYH,
    3. Chen SA,
    4. Chao TF
    . Importance of risk reassessment in patients with atrial fibrillation in guidelines: assessing risk as a dynamic process. Can J Cardiol 2019; 35(5):611–618. doi:10.1016/j.cjca.2019.01.018
    OpenUrlCrossRef
  7. ↵
    1. Lopes RD,
    2. Heizer G,
    3. Aronson R, et al
    . Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation. N Engl J Med 2019; 380(16):1509–1524. doi:10.1056/NEJMoa1817083
    OpenUrlCrossRefPubMed
  8. ↵
    1. Vranckx P,
    2. Valgimigli M,
    3. Eckardt L, et al
    . Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial. Lancet 2019; 394(10206):1335–1343. doi:10.1016/S0140-6736(19)31872-0
    OpenUrlCrossRefPubMed
  9. ↵
    1. January CT,
    2. Wann LS,
    3. Alpert JS, et al
    . 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014; 64(21):e1–e76. doi:10.1016/j.jacc.2014.03.022
    OpenUrlFREE Full Text
  10. ↵
    1. Yasuda S,
    2. Kaikita K,
    3. Akao M, et al
    . Antithrombotic therapy for atrial fibrillation with stable coronary disease. N Engl J Med 2019; 381(12):1103–1113. doi:10.1056/NEJMoa1904143
    OpenUrlCrossRefPubMed

This article requires you to have a ccjm.org account to view the full text. If you already have an account, you may log in below to view this article along with all other CCJM content. If you do not have an account, register here. It’s free!

Log in using your username and password

Forgot your user name or password?
PreviousNext
Back to top

Registration is Now Required for Free Access to CCJM Content

Register once and log in for full access to articles and content. Click “Register” in the upper right corner and follow the simple instructions to create a new account.

If you are using a mobile device, click on the settings icon to access the Register link.

In this issue

Cleveland Clinic Journal of Medicine: 87 (10)
Cleveland Clinic Journal of Medicine
Vol. 87, Issue 10
1 Oct 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Should we give triple therapy to patients with atrial fibrillation after percutaneous intervention?
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Should we give triple therapy to patients with atrial fibrillation after percutaneous intervention?
Asim Kichloo, Michael M. Aljadah, Farah Wani, Sindhura Ananthaneni
Cleveland Clinic Journal of Medicine Oct 2020, 87 (10) 599-601; DOI: 10.3949/ccjm.87a.19115

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Should we give triple therapy to patients with atrial fibrillation after percutaneous intervention?
Asim Kichloo, Michael M. Aljadah, Farah Wani, Sindhura Ananthaneni
Cleveland Clinic Journal of Medicine Oct 2020, 87 (10) 599-601; DOI: 10.3949/ccjm.87a.19115
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • WHICH ANTICOAGULANT? WHICH ANTIPLATELET DRUGS?
    • BENEFITS OF ANTICOAGULATION
    • EVIDENCE FOR DOUBLE THERAPY
    • PATIENTS AT HIGH RISK OF STROKE OR BLEEDING
    • TOOLS TO HELP DECISION-MAKING
    • WHEN TO DISCONTINUE THERAPY
    • TAKE-HOME MESSAGES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Does my healthy 65-year-old patient still need the 13-valent pneumococcal conjugate vaccine (PCV13)?
  • When is contrast needed for abdominal and pelvic CT?
Show more 1-Minute Consult

Similar Articles

Subjects

  • Hematology
  • Vascular Medicine
  • Drug Therapy
  • Cardiology

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit
  • Advertise Contact

Info For

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • Advertisers
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2021 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire